$930bn later, R&D is still a pancake
This article was originally published in Scrip
Executive Summary
In the past eight years (2006-2013), the global pharmaceutical and biotechnology industry has spent at least $930bn on drug research and development, according to data Scrip has accumulated from publicly-available company information.